Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced that Chen Schor,...
Source: marketscreener.com